Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study

BACKGROUND: Use of benzodiazepines (BZD) in patients receiving opioid agonist treatment (OAT) is common and associated with a variety of negative health and social outcomes. This cross-sectional study investigates the impact of BZD use in OAT patients on their quality of life (QoL). METHODS: A conve...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Maximilian, Gygli, Ferdinand, Westenberg, Jean N., Schmid, Otto, Strasser, Johannes, Lang, Undine E., Dürsteler, Kenneth M., Vogel, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354905/
https://www.ncbi.nlm.nih.gov/pubmed/37464432
http://dx.doi.org/10.1186/s13722-023-00397-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354905/
https://www.ncbi.nlm.nih.gov/pubmed/37464432
http://dx.doi.org/10.1186/s13722-023-00397-8

Ejemplares similares